nucleic acid drug candidates
Scope
Date
~
-
Capital raising
SK E&S' $2 bn preferred share deal shortlisted to four candidates
SK E&S Co., the largest city gas supplier in South Korea, has shortlisted four candidates among seven preliminary bidders to invest in 2 trillio...
Aug 13, 2021 (Gmt+09:00)
-
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language -
Entertainment
CJ joins race for over $200 mn stake in SM Entertainment
South Korea's entertainment- and food-focused CJ Group has emerged as a darkhorse to buy a controlling stake worth about 300 billion won ($260 milli...
Aug 03, 2021 (Gmt+09:00)
language -
Biotech
LegoChem’s biotech platform drives 28% share price spike over last month
The rise of the platform economy is a global phenomenon. The spread of the coronavirus pandemic has accelerated the use of contactless technology an...
Jul 07, 2021 (Gmt+09:00)
language -
ESG
Crude oil, nitric acid and yarn turn eco-friendly amid ESG boom
South Korean material makers are boosting their efforts to go green as they increasingly adopt eco-friendly technologies for raw materials such as c...
Jul 04, 2021 (Gmt+09:00)
language -
Pharmaceuticals
SK Biopharm aims to make it to global top 10 healthcare firms by 2030
South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...
Jul 02, 2021 (Gmt+09:00)
-
COVID-19
Eyegene to kick off Korea’s first mRNA clinical trial
Eyegene Inc. will be South Korea’s first vaccine maker to conduct clinical tests of messenger ribonucleic acid (mRNA) COVID-19 vaccines. Ealie...
Jul 01, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
Delivery Hero's Korean unit sale hits dead end
Delivery Hero SE on Thursday postponed the deadline again for the final bidding of South Korea's Yogiyo, amid market doubts over the country's No. 2...
Jun 24, 2021 (Gmt+09:00)
language -
Mergers & Acquisitions
Failed M&As in Korea now draw excess of candidates with better outlook
South Korea’s M&A market is heating up as the outlook for the global economic recovery is becoming more comfortable this year.The M&A ...
Jun 14, 2021 (Gmt+09:00)
language -
Medicine
Celltrion, Mirae to take largest stake in UK biotech firm
South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...
Jun 07, 2021 (Gmt+09:00)
language -
COVID-19 vaccines
Samsung Bio plans to manufacture mRNA drug substance from 2022
Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...
May 31, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience secures up to $173.4 mn from CEPI for vaccine development
SK Bioscience Co. has secured additional funding for phase III clinical trial of GBP510, its COVID-19 vaccine candidate jointly developed with the I...
May 24, 2021 (Gmt+09:00)
-
COVID-19
Genexine exports COVID vaccine candidate to Indonesia
Genexine Inc., one of the five South Korean pharmaceutical companies whose COVID-19 vaccine candidates have entered clinical trials, will export its...
Apr 28, 2021 (Gmt+09:00)
language -
Chemical Industry
Hanwha challenges monopoly in S.Korea’s nitric acid sector
South Korea’s industrial nitric acid sector, currently led by Hu-Chems Co. with around a 90% market share, will see a change in the competitiv...
Apr 21, 2021 (Gmt+09:00)
-
Industrial nitrates
Hu-Chems set to solidify nitric acid leadership with Asia’s largest capacity
The semiconductor chip manufacturing process requires wafer – a thin slice of semiconductor on which integrated circuits are fabricated – ...
Mar 12, 2021 (Gmt+09:00)
-
Drug development
SK injects $200 mn into Roivant partnership for new drug development
SK Holdings Co., the holding company of South Korean conglomerate SK Group, has become the first Korean company to foray into the targeted protein d...
Dec 07, 2020 (Gmt+09:00)
-
Bio
Celltrion to co-develop pill-type autoimmune disease drug with UK startup
Biosimilar maker Celltrion Inc. has agreed to develop a tablet-type treatment for autoimmune diseases jointly with the UK biotech startup Intract Phar...
Aug 20, 2020 (Gmt+09:00)
-
NPS tipped to restart CIO selection process in hunt for new candidates
The National Pension Service (NPS) has failed to choose a chief investment officer from 16 applicants and is likely to restart the selection process f...
Jun 25, 2018 (Gmt+09:00)
-
NPS kicks off CIO search process; no strong candidate yet
The National Pension Service (NPS), the world’s third-largest pension scheme, began the process of searching its new chief investment officer this wee...
Feb 20, 2018 (Gmt+09:00)
-
Korean VC firms invest in UK drug developer, first after Brexit
Celleron Therapeutics Ltd., a cancer treatment developer founded by Oxford University professors, is poised to attract $26 million from South Korean a...
Oct 17, 2016 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm subsidiary JVM to sell fully automated drug inspection machines in US
Hanmi Pharmaceutical said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug dis...
1 MINUTES AGO
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand